Staphylococcus aureus, methicillin resistant
Antibiotic |
% Susceptible |
Antibiotic |
% Susceptible |
|
| Ampicillin | 0 |
Imipenem | - |
|
| Azithromycin | 1 |
Levofloxacin | 34 |
|
| Aztreonam | - |
Meropenem | - |
|
| Cefazolin | 0 |
Moxifloxacin | 70
|
|
| Cefepime | - |
Nitrofurantoin | &
|
|
| Ceftazidime | - |
Oxacillin/Naf | - |
|
| Ceftriaxone | 0 |
Penicillin | 0 |
|
| Cefuroxime | - |
Piperacillin | -
|
|
| Ciprofloxacin | 34 |
Piperacillin/tazo | - |
|
| Clarithromycin | - |
Ticarcillin/Clav | - |
|
| Clindamycin | 43 |
Tobramycin | - |
|
| Doxycycline | 100 |
TMP/SMX | 98 |
|
| Erythromycin | 6 |
Unasyn/Aug | 0 |
|
| Gentamicin | - |
Vancomycin | 100 |
|
Comments:
Numeric data represent local susceptibility data.
(+) = usually effective or >60% susceptible; (+/-) = clinical trials lacking or 30-60% susceptible; (-) = not effective clinically or <30% susceptible - Adapted with permission from The Sanford Guide to Antimicrobial Therapy 2007
(*) Local (non-Sanford Guide) opinion
(S) = synergistic with penicillin/ampicillin;
(&) nitrofurantoin only useful for lower tract urinary tract infections
(+) = usually effective or >60% susceptible; (+/-) = clinical trials lacking or 30-60% susceptible; (-) = not effective clinically or <30% susceptible - Adapted with permission from The Sanford Guide to Antimicrobial Therapy 2007
(*) Local (non-Sanford Guide) opinion
(S) = synergistic with penicillin/ampicillin;
(&) nitrofurantoin only useful for lower tract urinary tract infections